JP2023514791A5 - - Google Patents

Info

Publication number
JP2023514791A5
JP2023514791A5 JP2022551254A JP2022551254A JP2023514791A5 JP 2023514791 A5 JP2023514791 A5 JP 2023514791A5 JP 2022551254 A JP2022551254 A JP 2022551254A JP 2022551254 A JP2022551254 A JP 2022551254A JP 2023514791 A5 JP2023514791 A5 JP 2023514791A5
Authority
JP
Japan
Prior art keywords
sequence
referred
pya
aza
conjugate according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022551254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514791A (ja
Filing date
Publication date
Priority claimed from GBGB2002705.8A external-priority patent/GB202002705D0/en
Application filed filed Critical
Publication of JP2023514791A publication Critical patent/JP2023514791A/ja
Publication of JP2023514791A5 publication Critical patent/JP2023514791A5/ja
Ceased legal-status Critical Current

Links

JP2022551254A 2020-02-26 2021-02-26 抗感染性二環式ペプチドコンジュゲート Ceased JP2023514791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2002705.8A GB202002705D0 (en) 2020-02-26 2020-02-26 Anti-infective bicyclic peptide conjugates
GB2002705.8 2020-02-26
PCT/GB2021/050490 WO2021171028A1 (en) 2020-02-26 2021-02-26 Anti-infective bicyclic peptide conjugates

Publications (2)

Publication Number Publication Date
JP2023514791A JP2023514791A (ja) 2023-04-10
JP2023514791A5 true JP2023514791A5 (enExample) 2024-03-01

Family

ID=70108245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551254A Ceased JP2023514791A (ja) 2020-02-26 2021-02-26 抗感染性二環式ペプチドコンジュゲート

Country Status (6)

Country Link
US (1) US20230086865A1 (enExample)
EP (1) EP4110400A1 (enExample)
JP (1) JP2023514791A (enExample)
CN (1) CN115551551A (enExample)
GB (1) GB202002705D0 (enExample)
WO (1) WO2021171028A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
NZ731185A (en) * 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2020084305A1 (en) * 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof

Similar Documents

Publication Publication Date Title
JP2023515567A5 (enExample)
JP2022546964A5 (enExample)
JP2023514791A (ja) 抗感染性二環式ペプチドコンジュゲート
MacDougall et al. Protein synthesis inhibitors and miscellaneous antibacterial agents
JP5773271B2 (ja) 抗菌適用のためのペプチド配列、それらの分岐形態、及びその使用
JP5207734B2 (ja) 細菌感染症を治療するためのダルババンシン組成物
KR102499670B1 (ko) 라이신 치환을 포함하는 Romo1 유래 항균 펩타이드 및 그 변이체
JP2023515567A (ja) Pbp3結合二環式ペプチドリガンド
AU2016287754A1 (en) Stabilized anti-microbial peptides
van der Goot Pore-forming toxins
US20150231199A1 (en) Peptides and their uses
JP6471236B2 (ja) ポリミキシン誘導体およびその使用
CN101641371A (zh) 肽及其用途
Conlon et al. Clinical applications of amphibian antimicrobial peptides
JP2020527164A (ja) グラム陰性病原体に対する抗微生物活性を示す抗微生物ペプチド及びその混合物
US20170348337A1 (en) Multifunctional membrane-active aminoglycoside-peptide conjugates
JP2022084752A (ja) 環状抗微生物性擬ペプチド及びその使用
AU2013226402B2 (en) Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
Ahrendt et al. Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue
US20110053834A1 (en) Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori and use thereof
JP2019529344A (ja) ランチビオティックバリアントおよびその使用
EP3323422A1 (en) New d-configured cateslytin peptide
JP2019529344A5 (enExample)
JP3488133B2 (ja) 抗菌性ペプチド
Patel et al. Emergence of methicillin-resistant staphylococcus aureus (MRSA) as a public-health threat and future directions of antibiotic therapy for MRSA infections